关键词：复用诊断；检测过程；诊断试验发展；运行检测程序
摘 要：Multiplexed diagnostics refer to equipment used for analyzing multiple analytes in a single cycle of an assay procedure. Multiplexed diagnostics are able to diagnose and run multiple tests on a specimen. These tools have evolved from diagnostic assays that screen a single analyte in one run of the assay procedure. Multiplexed diagnostics find their use in research and diagnostics laboratories. R&D laboratories use multiplexed assays in drug development procedures to screen multiple analytes. Multiplexed diagnostics are also used in various fields such as drug abuse screening, pharmacogenetics, and infection testing.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology6

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Application

07.1 Global Multiplexed Diagnostics Market by

Application

08. Market Segmentation by Technology

08.1 Global Medium-density Multiplexed Assays

Market

08.1.1 Market Size and Forecast

08.2 Global Low-density Multiplexed Assays Market

08.2.1 Market Size and Forecast

08.3 Global High-density Multiplexed Assays Market ..

08.3.1 Market Size and Forecast

08.4 Global Very High-density Multiplexed Assays

Market

08.4.1 Market Size and Forecast

08.5 Global Next-generation Sequencing Market

08.5.1 Market Size and Forecast

09. Geographical Segmentation

09.1 Multiplexed Diagnostics Market in Americas

09.1.1 Market Size and Forecast

09.2 Multiplexed Diagnostics Market in EMEA Region .

09.2.1 Market Size and Forecast

09.3 Multiplexed Diagnostics Market in APAC Region .

09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis 2013

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Affymetrix

18.1.1 Key Facts

18.1.2 Business Overview

18.1.3 Business Segmentation

18.1.4 Business Segmentation by Revenue 2013

18.1.5 Business Segmentation by Revenue 2012 and 2013

18.1.6 Sales by Geography

18.1.7 Business Strategy

18.1.8 Key Information

18.1.9 SWOT Analysis

18.2 Agilent Technologies

18.2.1 Key Facts

18.2.2 Business Overview

18.2.3 Business Segmentation by Revenue 2013

18.2.4 Business Segmentation by Revenue 2012 and 2013

18.2.5 Geographical Segmentation by Revenue 2013

18.2.6 Business Strategy

18.2.7 Recent Developments

18.2.8 SWOT Analysis

18.3 bioMérieux

18.3.1 Key Facts

18.3.2 Business Overview

18.3.3 Business Segmentation by Revenue 2013

18.3.4 Geographical Segmentation by Revenue 2013

18.3.5 Business Strategy

18.3.6 Recent Developments

18.3.7 SWOT Analysis

18.4 F. Hoffmann-La Roche

18.4.1 Key Facts

18.4.2 Business Overview

18.4.3 Business Segmentation

18.4.4 Business Segmentation by Revenue 2012 and 2013

18.4.5 Geographical Segmentation by Revenue

18.4.6 Business Strategy

18.4.7 Key Information

18.4.8 SWOT Analysis

18.5 Illumina

18.5.1 Key Facts

18.5.2 Business Overview

18.5.3 Business Segmentation

18.5.4 Sales by Geography

18.5.5 Business Strategy

18.5.6 Key Information

18.5.7 SWOT Analysis

18.6 Thermo Fisher Scientific

18.6.1 Key Facts

18.6.2 Business Overview

18.6.3 Business Segmentation

18.6.4 Business Segmentation by Revenue

18.6.5 Product Segmentation by Revenue

18.6.6 Geographical Segmentation by Revenue 2013

18.6.7 Business Strategy

18.6.8 Key Information

18.6.9 SWOT Analysis

19. Other Reports in this Series